CoverageForm 410-K10-Q8-K13D13G13F

VATE · Innovate Corp. - Financials

Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.

Price · VATE

Income Statement

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Revenue$364.80M-$347.10M$242.00M$315.20M-$242.20M$313.10M$315.20M-
Cost of Revenue$311.30M-$297.40M$196.40M$228.70M-$194.00M$247.50M$266.60M-
Gross Profit$53.50M-$49.70M$45.60M$45.50M-$48.20M$65.60M$48.60M-
R&D----------
SG&A$39.40M-$39.60M$35.10M$37.80M-$37.40M$42.90M$39.50M-
Total Operating Expenses----------
D&A$7.40M-$4.30M$4.40M$7.90M-$4.40M$4.40M$8.40M-
Operating Income$10.00M-$6.10M$4.90M$3.40M-$5.90M$28.80M$2.80M-
Interest Expense$24.50M-$21.20M$21.40M$17.20M---$17.20M-
Income Tax$2.90M-($7.10M)$4.20M$7.10M-$3.10M($2.50M)$3.30M-
Net Income($16.80M)-($8.90M)($19.80M)($24.50M)-($15.00M)$14.40M($17.40M)-
EPS - Basic($1.29)-($0.71)($1.67)($1.89)-($1.18)$1.10($2.20)-
EPS - Diluted($1.29)-($0.71)($1.67)($1.89)-($1.18)$1.00($2.20)-

Balance Sheet

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Cash & Equivalents$134.60M$112.10M$35.50M$33.40M$33.30M$48.80M$51.00M$80.20M$38.40M$80.80M
Accounts Receivable$194.00M$241.10M$265.60M$242.70M$164.50M$194.00M$190.80M$178.20M$250.40M$278.40M
Inventory$15.40M$16.00M$18.10M$20.70M$19.70M$20.80M$21.00M$20.90M$21.80M$22.40M
Accounts Payable----------
Current Assets$405.90M$451.50M$420.60M$398.40M$371.50M$390.90M$399.90M$394.90M$428.60M$517.90M
Total Assets$936.80M$950.10M$913.20M$890.90M$868.00M$891.10M$897.20M$898.90M$943.50M$1.04B
Current Liabilities$1.02B$1.03B$974.30M$873.10M$847.60M$483.00M$468.00M$289.30M$349.00M$413.80M
Long-term Debt----------
Total Liabilities$1.17B$1.17B$1.12B$1.08B$1.04B$1.03B$1.02B$1.01B$1.08B$1.18B
Stockholders' Equity($256.30M)($240.10M)($233.30M)($224.80M)($204.20M)($180.40M)($163.10M)($149.00M)($184.40M)($165.50M)
Retained Earnings($599.30M)($582.50M)($575.10M)($566.20M)($546.40M)($521.90M)($505.30M)($490.30M)($504.70M)($487.30M)

Cash Flow

Line itemQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Operating Cash Flow$45.50M---($14.10M)---($25.40M)-
Investing Cash Flow($9.60M)---($3.90M)---($3.30M)-
Financing Cash Flow($13.50M)---$2.40M---($12.90M)-
CapEx$0---$4.70M-$3.10M$3.10M$5.60M-
Free Cash Flow$45.50M---($18.80M)---($31.00M)-

Ratios

MetricQ1 '26Q4 '25Q3 '25Q2 '25Q1 '25Q4 '24Q3 '24Q2 '24Q1 '24Q4 '23
Profitability
Gross margin14.7%-14.3%18.8%14.4%-19.9%21.0%15.4%-
Operating margin2.7%-1.8%2.0%1.1%-2.4%9.2%0.9%-
EBITDA margin4.8%-3.0%3.8%3.6%-4.3%10.6%3.6%-
Net margin-4.6%--2.6%-8.2%-7.8%--6.2%4.6%-5.5%-
Free cash flow margin12.5%----6.0%----9.8%-
FCF / Net income-2.71---0.77---1.78-
R&D / Revenue----------
SG&A / Revenue10.8%-11.4%14.5%12.0%-15.4%13.7%12.5%-
Effective tax rate--------21.0%--
Return on assets-1.8%--1.0%-2.2%-2.8%--1.7%1.6%-1.8%-
Return on equity6.6%-3.8%8.8%12.0%-9.2%-9.7%9.4%-
Return on invested capital----------
Liquidity
Current ratio0.400.440.430.460.440.810.851.371.231.25
Quick ratio0.380.420.410.430.420.770.811.291.171.20
Cash ratio0.130.110.040.040.040.100.110.280.110.20
Leverage
Debt / Equity----------
Debt / Assets----------
Debt / EBITDA----------
Interest coverage0.4x-0.3x0.2x0.2x---0.2x-
Equity multiplier-3.66-3.96-3.91-3.96-4.25-4.94-5.50-6.03-5.12-6.31
Liabilities / Assets1.251.231.231.211.191.161.141.121.141.13
Efficiency
Asset turnover0.39-0.380.270.36-0.270.350.33-
Inventory turnover20.21-16.439.4911.61-9.2411.8412.23-
Days sales outstanding194d-279d366d190d-288d208d290d-
Days inventory outstanding18d-22d38d31d-40d31d30d-
Days payable outstanding----------
Cash conversion cycle----------
Valuation
P / E-------6.0x--
P / B----------
P / S0.2x-0.2x0.3x0.3x-0.2x2.8x1.7x-
EV / EBITDA-3.4x-2.8x3.7x6.1x--0.3x23.7x45.8x-
Growth
Revenue growth (YoY)15.7%-43.3%-22.7%0.0%--35.5%-15.1%-0.8%-
Revenue CAGR (3y)4.7%--6.4%-14.9%-8.6%--15.0%8.7%--
Revenue CAGR (5y)-------12.6%-9.6%-8.5%-
Gross profit growth (YoY)17.6%-3.1%-30.5%-6.4%--17.9%24.7%11.5%-
Operating income growth (YoY)194.1%-3.4%-83.0%21.4%--44.9%396.6%--
Net income growth (YoY)31.4%-40.7%--40.8%--114.3%--93.3%-
EPS growth (YoY)31.7%-39.8%-14.1%--1211.1%--1592.3%-
EPS CAGR (3y)----------
EPS CAGR (5y)----------
FCF growth (YoY)----39.4%---61.6%-
FCF CAGR (5y)----------
Book value growth (YoY)-25.5%-33.1%-43.0%-50.9%-10.7%-9.0%-3.3%1.3%-30.7%-36.4%

Sales by segment

From XBRL dimensional facts in the 10-K period ending 2025-12-31.

Business segments

$1.25B total
Infrastructure Segment$1.21B · 97.1%
Spectrum Segment$23.20M · 1.9%
Life Sciences Segment$12.50M · 1.0%

Product / service

$1.24B total
Commercial Revenue$371.90M · 29.9%
Industrial Revenue$306.60M · 24.6%
Transportation Revenue$192.90M · 15.5%
Healthcare Revenue$173.10M · 13.9%
Government Revenue$128.80M · 10.4%
Broadcast Station Revenue$23.20M · 1.9%
Energy Revenue$13.50M · 1.1%
Leisure Revenue$13.00M · 1.0%
Systems And Consumables Revenue$12.50M · 1.0%
Convention Revenue$8.80M · 0.7%

Peer comparison

Same SIC group: Fabricated Structural Metal Products

CompanyRevenue (last FY)Net marginROE
VMI$4.10B8.5%21.5%
ACA$2.88B7.2%7.9%
GIFI---
PRLB--3.2%
TPCS$34.03M-8.1%-31.4%

Comparing INNOVATE Corp. against the 5 most active filers in the same SIC group.

Dividends

$0.00/share trailing 12 months

Ex-datePer share
May 14, 2020$38.9000
Aug 28, 2013$85.0000
Dec 19, 2012$5.0000
Nov 23, 2012$25.0000
Jun 28, 2012$10.0000